Answers are grounded in this paper and cite their sources.
Patients with liver cirrhosis are known to have increased risk bleeding particularly from gastrointestinal tract.However, recent literature has shown that patients with liver cirrhosis are also at increased risk of developing deep venous thrombosis and pulmonary embolism.Therefore, it is important to consider prophylactic and therapeutic anticoagulation in cirrhotic patients.In this article, we have reviewed the available literature on the safety and efficacy of the utilization of prophylactic and therapeutic anticoagulation in cirrhotic patients.
No takes yet. Share an insight, caveat, or question.
Saad Qadwai (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: